Biosimilar Interchangeability

Interchangeability designations for biosimilars would make therapy substitutions easier for pharmacists, noted Steven Lucio of Novation, but the FDA has said they will not grant an interchangeability status to a biosimilar upon initial approval.

This video was shot at the 2013 Academy of Managed Care Pharmacy in San Antonio, Texas.